halama_immuno#pancreaticcancer or #PancreaticDuctalAdenoCarcinoma is a still an extreme challenge in #Oncology. New insights on #adjuvantchemotherapy after resection and prior #neoadjuvant #chemotherapy suggest a new direction, but many questions remain...what type of chemotherapy or what type of patient is able to go through this treatment?
https://ja.ma/3iKFwNN
https://ja.ma/3iKFwNN
Adjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy
This cohort study of data from the National Cancer Database on patients with pancreatic adenocarcinoma who received neoadjuvant chemotherapy compares overall survival between those who received adjuvant chemotherapy and those who did not.